abstract |
Novel 5-alkoxy tryptamine derivatives are provided, corresponding to the general formula: <IMAGE> in which R may be alkaline, X may be amino, and Y is various N-heterocyclic or N-branched chain moieties. The compounds show selective binding to 5-HT1D receptor subtypes, and have potential pharmaceutical utility in manufacture of migraine-treating drugs. |